rs3812052

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001256545.2(MEGF10):​c.3387T>A​(p.Gly1129Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.575 in 1,613,440 control chromosomes in the GnomAD database, including 275,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 20146 hom., cov: 32)
Exomes 𝑓: 0.58 ( 255403 hom. )

Consequence

MEGF10
NM_001256545.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.65

Publications

19 publications found
Variant links:
Genes affected
MEGF10 (HGNC:29634): (multiple EGF like domains 10) This gene encodes a member of the multiple epidermal growth factor-like domains protein family. The encoded protein plays a role in cell adhesion, motility and proliferation, and is a critical mediator of apoptotic cell phagocytosis as well as amyloid-beta peptide uptake in the brain. Expression of this gene may be associated with schizophrenia, and mutations in this gene are a cause of early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD) as well as congenital myopathy with minicores. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Apr 2012]
MEGF10 Gene-Disease associations (from GenCC):
  • MEGF10-related myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 5-127457282-T-A is Benign according to our data. Variant chr5-127457282-T-A is described in ClinVar as Benign. ClinVar VariationId is 262076.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.65 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.617 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEGF10NM_001256545.2 linkc.3387T>A p.Gly1129Gly synonymous_variant Exon 25 of 25 ENST00000503335.7 NP_001243474.1 Q96KG7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEGF10ENST00000503335.7 linkc.3387T>A p.Gly1129Gly synonymous_variant Exon 25 of 25 1 NM_001256545.2 ENSP00000423354.2 Q96KG7-1
MEGF10ENST00000274473.6 linkc.3387T>A p.Gly1129Gly synonymous_variant Exon 26 of 26 1 ENSP00000274473.6 Q96KG7-1
MEGF10ENST00000515622.1 linkn.433+1675T>A intron_variant Intron 4 of 4 2

Frequencies

GnomAD3 genomes
AF:
0.484
AC:
73459
AN:
151854
Hom.:
20144
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.226
Gnomad AMI
AF:
0.754
Gnomad AMR
AF:
0.506
Gnomad ASJ
AF:
0.597
Gnomad EAS
AF:
0.299
Gnomad SAS
AF:
0.445
Gnomad FIN
AF:
0.602
Gnomad MID
AF:
0.671
Gnomad NFE
AF:
0.622
Gnomad OTH
AF:
0.523
GnomAD2 exomes
AF:
0.528
AC:
132339
AN:
250420
AF XY:
0.538
show subpopulations
Gnomad AFR exome
AF:
0.219
Gnomad AMR exome
AF:
0.461
Gnomad ASJ exome
AF:
0.601
Gnomad EAS exome
AF:
0.294
Gnomad FIN exome
AF:
0.601
Gnomad NFE exome
AF:
0.624
Gnomad OTH exome
AF:
0.574
GnomAD4 exome
AF:
0.584
AC:
853559
AN:
1461468
Hom.:
255403
Cov.:
57
AF XY:
0.584
AC XY:
424335
AN XY:
727024
show subpopulations
African (AFR)
AF:
0.214
AC:
7162
AN:
33474
American (AMR)
AF:
0.467
AC:
20861
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.608
AC:
15900
AN:
26132
East Asian (EAS)
AF:
0.292
AC:
11599
AN:
39690
South Asian (SAS)
AF:
0.478
AC:
41173
AN:
86206
European-Finnish (FIN)
AF:
0.602
AC:
32060
AN:
53294
Middle Eastern (MID)
AF:
0.639
AC:
3684
AN:
5764
European-Non Finnish (NFE)
AF:
0.618
AC:
687168
AN:
1111852
Other (OTH)
AF:
0.562
AC:
33952
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
18991
37981
56972
75962
94953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18156
36312
54468
72624
90780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.483
AC:
73466
AN:
151972
Hom.:
20146
Cov.:
32
AF XY:
0.483
AC XY:
35869
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.226
AC:
9362
AN:
41432
American (AMR)
AF:
0.505
AC:
7715
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.597
AC:
2073
AN:
3470
East Asian (EAS)
AF:
0.299
AC:
1540
AN:
5150
South Asian (SAS)
AF:
0.446
AC:
2146
AN:
4816
European-Finnish (FIN)
AF:
0.602
AC:
6359
AN:
10558
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.622
AC:
42274
AN:
67954
Other (OTH)
AF:
0.527
AC:
1114
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1742
3483
5225
6966
8708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.585
Hom.:
8609
Bravo
AF:
0.466
Asia WGS
AF:
0.398
AC:
1383
AN:
3478
EpiCase
AF:
0.633
EpiControl
AF:
0.641

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 53% of total chromosomes in ExAC -

MEGF10-related myopathy Benign:3
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.12
DANN
Benign
0.38
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3812052; hg19: chr5-126792974; COSMIC: COSV57245128; COSMIC: COSV57245128; API